FDA has accepted a qualified health claim petition submitted by Danone North America on the ability of yogurt to reduce the risk of type 2 diabetes.  FDA is accepting comments on the petition until June 11, 2019.

Danone is requesting FDA’s consideration of the following qualified claims: (1) “Eating yogurt regularly may reduce the risk of type 2 diabetes.  FDA has concluded there is limited information supporting this claim;” or (2) “Eating yogurt regularly may reduce the risk of type 2 diabetes according to limited scientific evidence.”

Danone has requested the claim only for yogurts meeting the standards of identity under 21 C.F.R. §§ 131.200 (“Yogurt”), 131.203(“Lowfat yogurt”), and 131.206 (“Nonfat yogurt”).  Thus, non-dairy yogurts will not be eligible to make the claim if the petition is successful.